| Primary |
| Infection |
18.8% |
| Urinary Tract Infection |
18.8% |
| Cellulitis |
12.5% |
| Malaria Prophylaxis |
6.3% |
| Upper Respiratory Tract Infection |
5.2% |
| Hiv Infection |
4.2% |
| Hypertension |
3.1% |
| Nocardiosis |
3.1% |
| Prostatitis |
3.1% |
| Respiratory Tract Infection |
3.1% |
| Staphylococcal Abscess |
3.1% |
| Status Epilepticus |
3.1% |
| Antibiotic Prophylaxis |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Pneumocystis Jirovecii Pneumonia |
2.1% |
| Pneumonia |
2.1% |
| Uti |
2.1% |
| Cellulitis |
1.0% |
|
| Renal Failure Acute |
29.1% |
| Rash |
12.6% |
| Vomiting |
8.7% |
| Urticaria |
5.8% |
| Hyperkalaemia |
4.9% |
| Stevens-johnson Syndrome |
4.9% |
| Thrombocytopenia |
4.9% |
| Angioedema |
3.9% |
| Drug Hypersensitivity |
3.9% |
| Anaphylactic Reaction |
1.9% |
| Blood Urea Increased |
1.9% |
| Hypersensitivity |
1.9% |
| Pancreatitis |
1.9% |
| Pruritus |
1.9% |
| Pyrexia |
1.9% |
| Skin Exfoliation |
1.9% |
| Swelling Face |
1.9% |
| Swollen Tongue |
1.9% |
| Tubulointerstitial Nephritis |
1.9% |
| White Blood Cell Count Decreased |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.0% |
| Prophylaxis |
17.2% |
| Rheumatoid Arthritis |
13.1% |
| Acute Lymphocytic Leukaemia |
7.0% |
| Hiv Infection |
4.5% |
| Chronic Lymphocytic Leukaemia |
3.7% |
| Prophylaxis Against Transplant Rejection |
3.7% |
| Bacterial Infection |
3.3% |
| Nephrogenic Anaemia |
3.3% |
| Abscess |
2.9% |
| Leptospirosis |
2.5% |
| Scrub Typhus |
2.5% |
| Respiratory Tract Infection |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Antibiotic Prophylaxis |
1.6% |
| Cholestasis |
1.6% |
| Diabetes Mellitus |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Infective Tenosynovitis |
1.6% |
| Leukaemia Plasmacytic |
1.6% |
|
| Drug Hypersensitivity |
8.6% |
| Renal Failure Acute |
8.6% |
| Toxic Epidermal Necrolysis |
8.6% |
| White Blood Cell Count Decreased |
8.6% |
| Acute Psychosis |
5.7% |
| Delirium |
5.7% |
| Drug Ineffective |
5.7% |
| Nasopharyngitis |
5.7% |
| Renal Impairment |
5.7% |
| Stevens-johnson Syndrome |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Agranulocytosis |
2.9% |
| Angioedema |
2.9% |
| Autoimmune Thrombocytopenia |
2.9% |
| Colitis |
2.9% |
| Completed Suicide |
2.9% |
| Death |
2.9% |
| Disease Progression |
2.9% |
| Drug Resistance |
2.9% |
| Drug-induced Liver Injury |
2.9% |
|
| Concomitant |
| B-cell Lymphoma |
15.8% |
| Product Used For Unknown Indication |
14.7% |
| Diffuse Large B-cell Lymphoma |
11.2% |
| Prophylaxis |
10.9% |
| Drug Use For Unknown Indication |
7.1% |
| Adverse Event |
5.8% |
| Infection Prophylaxis |
4.3% |
| Rheumatoid Arthritis |
3.5% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Constipation |
2.6% |
| Hypertension |
2.6% |
| Prophylaxis Against Graft Versus Host Disease |
2.6% |
| Premedication |
2.3% |
| Chronic Lymphocytic Leukaemia |
2.2% |
| Hiv Infection |
2.1% |
| Pain |
2.1% |
| Prophylaxis Of Nausea And Vomiting |
2.1% |
| Depression |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.9% |
| Contraception |
1.8% |
|
| Pulmonary Embolism |
12.8% |
| Pain |
11.5% |
| Vomiting |
11.5% |
| Thrombocytopenia |
7.7% |
| Wrong Technique In Drug Usage Process |
7.7% |
| Pyrexia |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Pneumonia |
3.8% |
| Pruritus |
3.8% |
| Staphylococcal Infection |
3.8% |
| Vision Blurred |
3.8% |
| Blood Creatinine Increased |
2.6% |
| Cholecystitis Chronic |
2.6% |
| Circulatory Collapse |
2.6% |
| Deep Vein Thrombosis |
2.6% |
| Gastric Haemorrhage |
2.6% |
| Infusion Site Erythema |
2.6% |
| Interstitial Lung Disease |
2.6% |
| Osteonecrosis |
2.6% |
| Prostate Cancer |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
87.5% |
| Metastatic Malignant Melanoma |
12.5% |
|
|
